Safety and Tolerability of PQ912 in Subjects With Early Alzheimer's Disease
Clinical trial NCT02389413 · COMPLETED
Trial details
- NCT number
- NCT02389413
- Sponsor
- Vivoryon Therapeutics N.V.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2017-04-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.